FR2614790B1 - Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique - Google Patents

Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique

Info

Publication number
FR2614790B1
FR2614790B1 FR888805735A FR8805735A FR2614790B1 FR 2614790 B1 FR2614790 B1 FR 2614790B1 FR 888805735 A FR888805735 A FR 888805735A FR 8805735 A FR8805735 A FR 8805735A FR 2614790 B1 FR2614790 B1 FR 2614790B1
Authority
FR
France
Prior art keywords
eicosapeutaenoic
acid
composition based
ophthalmological composition
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR888805735A
Other languages
English (en)
Other versions
FR2614790A1 (fr
Inventor
Pierre Braquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of FR2614790A1 publication Critical patent/FR2614790A1/fr
Application granted granted Critical
Publication of FR2614790B1 publication Critical patent/FR2614790B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR888805735A 1987-05-07 1988-04-29 Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique Expired - Fee Related FR2614790B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878710780A GB8710780D0 (en) 1987-05-07 1987-05-07 Opthalmological application of eicosapentaenoic acid

Publications (2)

Publication Number Publication Date
FR2614790A1 FR2614790A1 (fr) 1988-11-10
FR2614790B1 true FR2614790B1 (fr) 1991-05-31

Family

ID=10616936

Family Applications (1)

Application Number Title Priority Date Filing Date
FR888805735A Expired - Fee Related FR2614790B1 (fr) 1987-05-07 1988-04-29 Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique

Country Status (19)

Country Link
US (1) US4897421A (fr)
JP (1) JPS63297323A (fr)
KR (1) KR880013557A (fr)
AU (1) AU1567888A (fr)
BE (1) BE1001075A3 (fr)
CH (1) CH675359A5 (fr)
DE (1) DE3815581A1 (fr)
DK (1) DK250088A (fr)
FR (1) FR2614790B1 (fr)
GB (2) GB8710780D0 (fr)
IN (1) IN169811B (fr)
IT (1) IT1217446B (fr)
LU (1) LU87210A1 (fr)
MY (1) MY103079A (fr)
NL (1) NL8801125A (fr)
NZ (1) NZ224363A (fr)
OA (1) OA08843A (fr)
SE (1) SE8801710L (fr)
ZA (1) ZA882963B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2136252C1 (ru) * 1995-01-20 1999-09-10 Вакамото Фармасьютикал Ко., Лтд. Противовоспалительные глазные капли

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657018A1 (fr) * 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
DE69004081T2 (de) * 1990-05-23 1994-02-10 Nestle Sa Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
US5444452A (en) * 1992-07-13 1995-08-22 Matsushita Electric Works, Ltd. Dual frequency antenna
DE4330664A1 (de) * 1993-09-10 1995-03-16 Beiersdorf Ag Verwendungen von Pflanzenölen
FR2722410B1 (fr) * 1994-07-15 1996-10-04 Grinda Jean Robert Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US20040014812A1 (en) * 2000-11-08 2004-01-22 Santen Pharmaceutical Co. Ltd Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient
US20060009522A1 (en) * 2004-07-01 2006-01-12 Reza Dana Compositions and methods for treating eye disorders and conditions
US20070265341A1 (en) * 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
BRPI0612596A2 (pt) * 2005-07-01 2010-11-23 Sigma Tau Ind Farmaceuti uso de l-carnitina ou alcanoil-l-carnitinas para a preparação de um suplemento ou medicamento fisiológico para uso oftálmico na forma de gotas oftálmicas

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT269345B (de) * 1965-07-20 1969-03-10 Merck & Co Inc Verfahren zur Herstellung einer sterilen, von festen Teilchen freien Zubereitung für die Augenheilkunde
US3549747A (en) * 1968-02-20 1970-12-22 Flow Pharma Inc Contact lens wetting solution and method of using same
GB1340517A (en) * 1969-12-01 1973-12-12 Burton Parsons Chemicals Inc Ophthalmic solution
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
GB2020180B (en) * 1978-05-08 1982-08-25 Nelson Res & Dev Ophthalmic compositions containingcolchicine or vinblastinr
AU527784B2 (en) * 1978-05-26 1983-03-24 Bang, Hans Olaf Dr. Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
US4616012A (en) * 1983-11-25 1986-10-07 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
JPS6344843A (ja) * 1986-08-13 1988-02-25 Kao Corp 油中水中油型乳化油脂組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2136252C1 (ru) * 1995-01-20 1999-09-10 Вакамото Фармасьютикал Ко., Лтд. Противовоспалительные глазные капли

Also Published As

Publication number Publication date
US4897421A (en) 1990-01-30
DK250088A (da) 1988-11-08
GB8810422D0 (en) 1988-06-08
SE8801710L (sv) 1988-11-08
CH675359A5 (fr) 1990-09-28
IT8820388A0 (it) 1988-04-29
JPS63297323A (ja) 1988-12-05
MY103079A (en) 1993-04-30
LU87210A1 (fr) 1988-12-13
ZA882963B (en) 1988-10-28
KR880013557A (ko) 1988-12-21
IN169811B (fr) 1991-12-28
NZ224363A (en) 1990-03-27
GB8710780D0 (en) 1987-06-10
DK250088D0 (da) 1988-05-06
GB2204239B (en) 1990-11-28
DE3815581A1 (de) 1988-11-17
NL8801125A (nl) 1988-12-01
IT1217446B (it) 1990-03-22
BE1001075A3 (fr) 1989-06-27
SE8801710D0 (sv) 1988-05-05
GB2204239A (en) 1988-11-09
OA08843A (fr) 1989-03-31
FR2614790A1 (fr) 1988-11-10
AU1567888A (en) 1988-11-10

Similar Documents

Publication Publication Date Title
MC1881A1 (fr) Derives de l'acide phosphinique
FR2552993B1 (fr) Composition pharmaceutique ophtalmique a base d'un derive d'acide phenylacetique
MC2106A1 (fr) Derives d'aminoacides
PT87422A (pt) Procede de preparation d'une forme de dosage solide pharmaceutque a base de cimetidine
FR2617935B1 (fr) Volant d'inertie divise
MC2103A1 (fr) Derives d'aminoacides
FR2614790B1 (fr) Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique
FR2580495B1 (fr) Preparation dentaire a base d'emulsanne
OA08269A (fr) Compositions stables à base d'interféron-gamma
FR2640263B1 (fr) Preparation d'acide levulinique
FR2604812B1 (fr) Element d'affichage
BE850972A (fr) Nouvelle composition therapeutique a base d'acide chenodesocycholique
MC1960A1 (fr) Derives d'acide hydrocinnamique
DK482488A (da) 3'-demethoxyepipodophyllotoxinglucosidderivater
OA08430A (fr) Composition fongicide à base d'un dérivé de l'acide phosphoreux.
FR2577928B1 (fr) Analogues d'amino-prostaglandines a substituant thiabicycloheptane
FR2544198B1 (fr) Compositions pharmaceutiques topiques a base d'acide meclophenamique
FR2605435B3 (fr) Panneau d'affichage
FR2574663B1 (fr) Nouvelle composition therapeutique a activite antithrombotique et hypolipemiante a base de xylanes et d'un acide organique
FR2541895B1 (fr) Composition deodorante et antitranspirante a base d'acide triterpenique
TR23855A (tr) Sulfosuksinik asit monoamid'ler esasina dayanan yaglama maddeleri
FR2609287B1 (fr) Procede de preparation d'un acide 4-trifluoromethyl-2-nitrobenzoique et d'un nouvel isomere
FR2494113B1 (fr) Nouvelle association medicamenteuse a base d'acide l-aspartique et de l-arginine
FR2547729B1 (fr) Medicament a base d'acide dl thiazolidine carboxylique
FR2594334B1 (fr) Composition pharmaceutique injectable a base d'amoxicilline

Legal Events

Date Code Title Description
ST Notification of lapse